Introducing Clear Dx™
A fully automated, next-generation sequencing platform that offers complete characterization SARS-CoV-2 and its variants of concern. Built to deliver accurate and near real-time results, Clear Dx™ is revolutionizing the way clinical and public health labs approach genomic and pathogen surveillance.
Unrivaled Speed and Flexibility
Our fully automated sequencing platform helps you work quickly and efficiently—offering you the agility to address the rapidly evolving COVID-19 pandemic and more productive time to perform other lab tasks.
Leverage the utility of pathogen sequencing automation
Our liquid handling includes cDNA synthesis, amplification of targets, indexing, nucleic acid clean-up, and initiating the sequencing run with no manual library preparation required.
Go from RNA to results in hours
Clear Dx™ reduces hands-on time from 9 hours to less than 45 minutes, cuts down the number of human touch points from 100 manual steps to 1, and decreases the time to results from 4 to 10 days down to less than 24 hours.
Empowers timely decision-making
By enabling whole genome sequencing (WGS) monitoring for mutations in the SARS-CoV-2 viral genome, Clear Dx™ offers one seamless solution within a single lab shift, helping to facilitate more timely decision-making.
Clear Dx™ allows you to generate the same outcome repeatedly—which reduces workflow errors, increases the consistency of results, boosts your overall productivity, and ultimately improves your organization’s genomic surveillance.
Streamlined Data Management
With our comprehensive Clear Dx™ workflow, you can manage and interpret your data—and act on it accordingly—without the need for bioinformatics specialists. Featured in the platform are data integration and connectivity solutions that help to streamline pathogen surveillance of SARS-CoV-2.
Security and reliability
The Clear Dx™ software-as-a-service (SaaS) offering for SARS-CoV-2 metadata analysis places high priority on protecting the integrity and availability of customer data.
Bioinformatics built in
Open API integration as well as FASTA / FASTQ files and quality metrics for each sample are available for download after analysis.
Intuitive software interface
Perform simplified sample registration and result analysis without the need for manual, error-prone interaction.
Accessible and Easy to Use
Clear Dx’s comprehensive and fully automated sequencing platform significantly reduces the level of effort typically required for infectious disease surveillance.
Our whole genome sequencing (WGS) workflow consists of only one human touchpoint vs. a hundred.
Operate with agency
Increase lab tech productivity through automated sequencing, as technologists can perform other tasks after loading samples onto the Clear Dx™ instrument.
Experience the difference
Learn how the Clear Dx™ platform performs versus existing methods.